10 Patents
- 0 cites
- US123785462025Coupling Endonucleases with End-processing Enzymes Drives High Efficiency Gene Disruption
SEATTLE CHILDREN'S RESEARCH INSTITUTE
0 cites - US123589702025Methods of Exogenous Drug Activation of Chemical-induced Signaling Complexes Expressed in Engineered Cells in Vitro and in Vivo
Seattle Children's Hospital
0 cites - 0 cites
- US119590732024Coupling Endonucleases with End-processing Enzymes Drives High Efficiency Gene Disruption
SEATTLE CHILDREN'S RESEARCH INSTITUTE
0 cites - US119395942024Engraftable Cell-based Immunotherapy for Long-term Delivery of Therapeutic Proteins
Seattle Children's Hospital
0 cites - US118734792024Coupling Endonucleases with End-processing Enzymes Drives High Efficiency Gene Disruption
SEATTLE CHILDREN'S RESEARCH INSTITUTE
0 cites - US117534602023Methods of Exogenous Drug Activation of Chemical-induced Signaling Complexes Expressed in Engineered Cells in Vitro and in Vivo
Seattle Children's Hospital
0 cites - US117124542023Method for Treating Autoimmune Disease Using CD4 T-cells with Engineered Stabilization of Expression of Endogenous FOXP3 Gene
SEATTLE CHILDREN'S HOSPITAL
0 cites - 0 cites